These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 29316325)

  • 21. Considerations for Glycoprotein Production.
    Clarke EC
    Methods Mol Biol; 2024; 2762():329-351. PubMed ID: 38315375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CHO glycosylation mutants as potential host cells to produce therapeutic proteins with enhanced efficacy.
    Zhang P; Chan KF; Haryadi R; Bardor M; Song Z
    Adv Biochem Eng Biotechnol; 2013; 131():63-87. PubMed ID: 23142953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-Glycosylation Design and Control of Therapeutic Monoclonal Antibodies.
    Sha S; Agarabi C; Brorson K; Lee DY; Yoon S
    Trends Biotechnol; 2016 Oct; 34(10):835-846. PubMed ID: 27016033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The emerging role of cellular post-translational modifications in modulating growth and productivity of recombinant Chinese hamster ovary cells.
    Bryan L; Clynes M; Meleady P
    Biotechnol Adv; 2021; 49():107757. PubMed ID: 33895332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Model-based analysis of N-glycosylation in Chinese hamster ovary cells.
    Krambeck FJ; Bennun SV; Andersen MR; Betenbaugh MJ
    PLoS One; 2017; 12(5):e0175376. PubMed ID: 28486471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Application of Unfolded Protein Response for Production of Biologics].
    Omasa T
    Yakugaku Zasshi; 2016; 136(6):831-9. PubMed ID: 27252063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glyco-Mapper: A Chinese hamster ovary (CHO) genome-specific glycosylation prediction tool.
    Kremkow BG; Lee KH
    Metab Eng; 2018 May; 47():134-142. PubMed ID: 29522825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors affecting the expression of recombinant glycoproteins.
    Devasahayam M
    Indian J Med Res; 2007 Jul; 126(1):22-7. PubMed ID: 17890819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel recombinant human lactoferrin: differential activation of oxidative stress related gene expression.
    Kruzel ML; Actor JK; Zimecki M; Wise J; Płoszaj P; Mirza S; Kruzel M; Hwang SA; Ba X; Boldogh I
    J Biotechnol; 2013 Dec; 168(4):666-75. PubMed ID: 24070904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycosylation of therapeutic proteins in different production systems.
    Werner RG; Kopp K; Schlueter M
    Acta Paediatr; 2007 Apr; 96(455):17-22. PubMed ID: 17391433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A global RNA-seq-driven analysis of CHO host and production cell lines reveals distinct differential expression patterns of genes contributing to recombinant antibody glycosylation.
    Könitzer JD; Müller MM; Leparc G; Pauers M; Bechmann J; Schulz P; Schaub J; Enenkel B; Hildebrandt T; Hampel M; Tolstrup AB
    Biotechnol J; 2015 Sep; 10(9):1412-23. PubMed ID: 26212696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of bisected glycoforms of recombinant IFN-beta by overexpression of beta-1,4-N-acetylglucosaminyltransferase III in Chinese hamster ovary cells.
    Sburlati AR; Umaña P; Prati EG; Bailey JE
    Biotechnol Prog; 1998; 14(2):189-92. PubMed ID: 9548768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glyco-engineered CHO cell lines producing alpha-1-antitrypsin and C1 esterase inhibitor with fully humanized N-glycosylation profiles.
    Amann T; Hansen AH; Kol S; Hansen HG; Arnsdorf J; Nallapareddy S; Voldborg B; Lee GM; Andersen MR; Kildegaard HF
    Metab Eng; 2019 Mar; 52():143-152. PubMed ID: 30513349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-free protein expression based on extracts from CHO cells.
    Brödel AK; Sonnabend A; Kubick S
    Biotechnol Bioeng; 2014 Jan; 111(1):25-36. PubMed ID: 24018795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycoengineering design options for IgG1 in CHO cells using precise gene editing.
    Schulz MA; Tian W; Mao Y; Van Coillie J; Sun L; Larsen JS; Chen YH; Kristensen C; Vakhrushev SY; Clausen H; Yang Z
    Glycobiology; 2018 Jul; 28(7):542-549. PubMed ID: 29596681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in the understanding of biological implications and modulation methodologies of monoclonal antibody N-linked high mannose glycans.
    Shi HH; Goudar CT
    Biotechnol Bioeng; 2014 Oct; 111(10):1907-19. PubMed ID: 24975601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A high density CHO-S transient transfection system: Comparison of ExpiCHO and Expi293.
    Jain NK; Barkowski-Clark S; Altman R; Johnson K; Sun F; Zmuda J; Liu CY; Kita A; Schulz R; Neill A; Ballinger R; Patel R; Liu J; Mpanda A; Huta B; Chiou H; Voegtli W; Panavas T
    Protein Expr Purif; 2017 Jun; 134():38-46. PubMed ID: 28342833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Array-based analysis of secreted glycoproteins for rapid selection of a single cell producing a glycoprotein with desired glycosylation.
    Park S; Kim W; Kim Y; Son YD; Lee SC; Kim E; Kim SH; Kim JH; Kim HS
    Anal Chem; 2010 Jul; 82(13):5830-7. PubMed ID: 20550136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low glucose depletes glycan precursors, reduces site occupancy and galactosylation of a monoclonal antibody in CHO cell culture.
    Villacrés C; Tayi VS; Lattová E; Perreault H; Butler M
    Biotechnol J; 2015 Jul; 10(7):1051-66. PubMed ID: 26058832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The emerging CHO systems biology era: harnessing the 'omics revolution for biotechnology.
    Kildegaard HF; Baycin-Hizal D; Lewis NE; Betenbaugh MJ
    Curr Opin Biotechnol; 2013 Dec; 24(6):1102-7. PubMed ID: 23523260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.